跳至主要内容
临床试验/NCT03860090
NCT03860090Unknown不适用

Prospective Randomized Comparison of Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access. The CEPHAX Study.

Castilla-La Mancha Health Service2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
240
试验地点
2
主要终点
Implant Success

研究概览

简要总结

This clinical trial evaluates the efficacy and safety of axillary versus cephalic venous access in the pacemakers and defibrillators implantation.

Half of participants will receive the implant via fluoroscopy guided axillary venous access and the other half will receive the implant via improved cephalic venous access.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a endovenous pacemaker or defibrillator indication.

排除标准

  • Pre-existing ipsilateral pacing electrode.
  • Previous ipsilateral lymphadenectomy.
  • Indication of cardiac resynchronization therapy.

结局指标

主要结局

Implant Success

时间窗: 30 days

Success of the implant through the assigned access vein

Implant Complications

时间窗: 30 days

All implant related complications

次要结局

  • Lead Complications(From date of implant until the date of first documented, assessed up to 48 months)
  • Pneumothorax(30 days)
  • Bleeding(30 days)
  • Upper limb thrombosis(From date of implant until the date of first documented, assessed up to 48 months)

研究者

发起方
Castilla-La Mancha Health Service
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验